BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28499874)

  • 1. Pyrrole-indolinone SU11652 targets the nucleoside diphosphate kinase from Leishmania parasites.
    Vieira PS; Souza TACB; Honorato RV; Zanphorlin LM; Severiano KU; Rocco SA; de Oliveira AHC; Cordeiro AT; Oliveira PSL; de Giuseppe PO; Murakami MT
    Biochem Biophys Res Commun; 2017 Jul; 488(3):461-465. PubMed ID: 28499874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel inhibitors for Leishmania nucleoside diphosphatase kinase (NDK) based on its structural and functional characterization.
    Mishra AK; Singh N; Agnihotri P; Mishra S; Singh SP; Kolli BK; Chang KP; Sahasrabuddhe AA; Siddiqi MI; Pratap JV
    J Comput Aided Mol Des; 2017 Jun; 31(6):547-562. PubMed ID: 28551817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the C-terminus and Kpn loop in the quaternary structure stability of nucleoside diphosphate kinase from Leishmania parasites.
    Vieira PS; de Giuseppe PO; de Oliveira AHC; Murakami MT
    J Struct Biol; 2015 Dec; 192(3):336-341. PubMed ID: 26410384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical Characterization of the Nucleoside Diphosphate Kinase of Leishmania major and Effect of the P95S Mutation.
    Vieira PS; de Jesus Santos AP; de Oliveira AH
    Protein Pept Lett; 2016; 23(2):99-106. PubMed ID: 26548994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular adaptability of nucleoside diphosphate kinase b from trypanosomatid parasites: stability, oligomerization and structural determinants of nucleotide binding.
    Souza TA; Trindade DM; Tonoli CC; Santos CR; Ward RJ; Arni RK; Oliveira AH; Murakami MT
    Mol Biosyst; 2011 Jul; 7(7):2189-95. PubMed ID: 21528129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase.
    Kaur J; Kaur B; Singh P
    Bioorg Med Chem Lett; 2018 Jan; 28(2):129-133. PubMed ID: 29208523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression in E. coli and purification of the nucleoside diphosphate kinase b from Leishmania major.
    de Oliveira AH; Ruiz JC; Cruz AK; Greene LJ; Rosa JC; Ward RJ
    Protein Expr Purif; 2006 Oct; 49(2):244-50. PubMed ID: 16809050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural modeling and docking studies of ribose 5-phosphate isomerase from Leishmania major and Homo sapiens: a comparative analysis for Leishmaniasis treatment.
    Capriles PV; Baptista LP; Guedes IA; Guimarães AC; Custódio FL; Alves-Ferreira M; Dardenne LE
    J Mol Graph Model; 2015 Feb; 55():134-47. PubMed ID: 25528729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
    Sanderson L; Yardley V; Croft SL
    J Antimicrob Chemother; 2014 Jul; 69(7):1888-91. PubMed ID: 24668412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.
    Marhadour S; Marchand P; Pagniez F; Bazin MA; Picot C; Lozach O; Ruchaud S; Antoine M; Meijer L; Rachidi N; Le Pape P
    Eur J Med Chem; 2012 Dec; 58():543-56. PubMed ID: 23164660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production, purification, crystallization and preliminary X-ray diffraction studies of the nucleoside diphosphate kinase b from Leishmania major.
    Tonoli CC; Vieira PS; Ward RJ; Arni RK; de Oliveira AH; Murakami MT
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Nov; 65(Pt 11):1116-9. PubMed ID: 19923730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure and biophysical characterization of the nucleoside diphosphate kinase from Leishmania braziliensis.
    Vieira PS; de Giuseppe PO; Murakami MT; de Oliveira AH
    BMC Struct Biol; 2015 Feb; 15():2. PubMed ID: 25643978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
    Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
    Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.
    Walker RG; Thomson G; Malone K; Nowicki MW; Brown E; Blake DG; Turner NJ; Walkinshaw MD; Grant KM; Mottram JC
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1033. PubMed ID: 21483720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards discovery of new leishmanicidal scaffolds able to inhibit
    Martínez de Iturrate P; Sebastián-Pérez V; Nácher-Vázquez M; Tremper CS; Smirlis D; Martín J; Martínez A; Campillo NE; Rivas L; Gil C
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):199-210. PubMed ID: 31752556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Trypanothione Reductase of Leishmanial major to Fight Against Cutaneous Leishmaniasis.
    Dukhyil AAAB
    Infect Disord Drug Targets; 2019; 19(4):388-393. PubMed ID: 29732996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights.
    Majid Shah S; Ullah F; Ayaz M; Sadiq A; Hussain S; Ali Shah AU; Adnan Ali Shah S; Wadood A; Nadhman A
    Steroids; 2019 Aug; 148():56-62. PubMed ID: 31085212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking.
    Brindisi M; Brogi S; Relitti N; Vallone A; Butini S; Gemma S; Novellino E; Colotti G; Angiulli G; Di Chiaro F; Fiorillo A; Ilari A; Campiani G
    Sci Rep; 2015 May; 5():9705. PubMed ID: 25951439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
    Řezníčková E; Popa A; Gucký T; Zatloukal M; Havlíček L; Bazgier V; Berka K; Jorda R; Popa I; Nasereddin A; Jaffe CL; Kryštof V; Strnad M
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2298-301. PubMed ID: 25937014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
    Datta AK; Datta R; Sen B
    Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.